Desulfovibrio piger is part of a group called Sulfate-reducing bacteria (=SRB). SRBs are normal inhabitants of the intestine in humans. This group of bacteria can “breathe” sulfate rather than oxygen. SRBs have been suspected to contribute to gastrointestinal disease due to the production of hydrogen sulfide, which can be considered toxic to the gut epithelium. Desulfovibrio piger is an SRB from the Proteobacterium phylum (deltaproteobacterium) and formerly known as Desulfomonas pigra, is a Gram-negative, nonmotile, rod-shaped bacterium 0.8 to 1.3 μm ×1.2 to 5 μm in size.
In a study highlighting its potential involvement in inflammatory bowel diseases (IBDs), Desulfovibrio piger‘s prevalence was shown to be significantly higher in IBD patients compared to healthy individuals or non-IBD patients [L].
References:
– Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases [L]
– Desulfovibrio species are potentially important in regressive autism [L]
– Screening of sulfate-reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa. [L]
– Clinical significance of sulfate-reducing bacteria for ulcerative colitis [L]
– Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. [L]
– Diversity and distribution of sulphate-reducing bacteria in human feces from healthy subjects and patients with inflammatory bowel disease [L]
– Complete Genome Sequence of Desulfovibrio piger FI11049 [L]
Understand and improve your laboratory results with our health dashboard.
Upload your lab reports and get interpretation today.
Our technology helps to understand, combine, track, organize, and act on your medical lab test results.
Although Desulfovibrio piger bacteria are found in some healthy human guts, a greater abundance of this species may be associated with certain gastrointestinal diseases, such as Inflammatory Bowel Disease.
A study has revealed that the prevalence of Desulfovibrio pigerwas significantly higher in inflammatory bowel disease patients as compared to healthy individuals (L). However, results from other literature do not show a clear association between sulphate reducing bacteria and IBD. [L, L, L]
Possible treatment:
Avoid food high in fat and simple sugars. [L]
Interpret Your Lab Results
Upload your lab report and we’ll interpret and provide you with recomendations today.
Get StartedGet Started With Our Personal Plan
Advanced Plan
Unlimited Plan
Are You a Health Professional?
Get started with our professional plan
Welcome to Healthmatters Pro.
Save time on interpreting lab results with the largest database of biomarkers online. In-depth research on any test at your fingertips, all stored and tracked in one place. Learn more
Pro Plan
for health professionals
$45 per month
At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.
Acetate, Akkermansia muciniphila, Anaerotruncus colihominis, Anaerotruncus colihominis/massiliensis, Ancylostoma/Necator (Hookworm), Ascaris lumbricoides, Bacteroides uniformis, Bacteroides vulgatus, Bacteroides-Prevotella group, Barnesiella spp., Beta-glucuronidase, Bifidobacterium longum, Bifidobacterium longum subsp. longum, Bifidobacterium spp., Blastocystis spp., Butyrivibrio crossotus, Calprotectin, Candida albicans/dubliniensis, Capillaria philippinensis, Cholesterol, Citrobacter species, Clostridium spp., Collinsella aerofaciens, Coprococcus eutactus, Cryptosporidium parvum/hominis, Cyclospora cayetanensis, Desulfovibrio piger, Dientamoeba fragilis, Entamoeba histolytica, Enterobacter cloacae, Enterobius vermicularis, Enterococcus faecalis, Eosinophil Protein X, Escherichia coli, Faecalibacterium prausnitzii, Fecal Color, Fecal Consistency, Fecal Fat, Total, Fecal Occult Blood, Fecal secretory IgA, Firmicutes/Bacteroidetes (F/B Ratio), Fusobacterium spp., Giardia, Klebsiella oxytoca, Klebsiella species, Lactobacillus spp., Long-Chain Fatty Acids, Methanobrevibacter smithii, n-Butyrate %, n-Butyrate Concentration, Odoribacter spp., Oxalobacter formigenes, Pancreatic Elastase 1, Phocaeicola vulgatus, Phospholipids, Prevotella spp., Products of Protein Breakdown (Total), Propionate, Proteus mirabilis, Pseudoflavonifractor spp., Roseburia spp., Ruminococcus bromii, Ruminococcus spp., Short-Chain Fatty Acids (SCFA), Total, Triglycerides, Veillonella spp., Zonulin Family Peptide